Pseudomonas aeruginosa nozokominių padermių atsparumo antibiotikams lygmens pokyčiai didžiausioje Lietuvos universitetinėje ligoninėje
| Autor: | Astra Vitkauskienė, Asta Dambrauskienė, Dalia Adukauskienė, Agnė Vitkauskaitė, Erika Skrodenienė |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Cross Infection
Intensive care units Cross infection Pseudomonas aeruginosa Drug effects Anti-infective agents Therapeutic use Drug resistance microbial business.industry Becton dickinson Ceftazidime Lithuania General Medicine medicine.disease_cause resistance level of Pseudomonas aeruginosa to antibiotics multidrug resistance minimum inhibitory concentration Microbiology Ciprofloxacin Hospitals University Antibiotic resistance 616.9-022.363 [udc] Amikacin Intensive care Drug Resistance Bacterial medicine Humans Pseudomonas Infections business medicine.drug Piperacillin |
| Zdroj: | Medicina, Kaunas : Lietuvos sveikatos mokslų universitetas, 2011, t. 47, Nr. 5, p. 278-283 Medicina; Volume 47; Issue 5; Pages: 39 |
| ISSN: | 1648-9144 1010-660X |
| Popis: | The aim was to estimate changes in the resistance rates of Pseudomonas aeruginosa (P. aeruginosa) strains isolated from patients treated in intensive care units of the largest university hospital. Materials and Methods. Isolates were identified with the Phoenix ID system (Becton Dickinson, USA). The minimum inhibitory concentration (MIC) of ceftazidime, ciprofloxacin, and amikacin were determined by the E-test and evaluated following the recommendations of the Clinical Laboratory Standards Institute. Results. In 2003, the proportion of P. aeruginosa strains resistant to piperacillin was greatest followed by strains resistant gentamicin and ciprofloxacin. In 2008, the resistance rates markedly changed being the highest to ciprofloxacin. An increase in the resistance rates to ciprofloxacin (+24%, P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|